YANCOPOULOS GEORGE sold REGN
January 2, 2024 · Form 4 insider transaction
YANCOPOULOS GEORGE sold 16,848 shares of Regeneron Pharmaceuticals, Inc. at $900.00 per share, a transaction worth $15.16M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 120 days after the transaction.
Direction
Disposed (sell-side)
Shares
16,848
Price
$900.00
Total value
$15.16M
InsiderYANCOPOULOS GEORGE
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 2, 2024
Filing dateMay 1, 2024
Shares owned after180,000
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022.; As investment trustee of trusts for the benefit of the reporting person's children.